No Data
No Data
No Data
No Data
No Data
Sell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price Target
TipRanksMar 31 10:35 ET
Reneo Pharmaceuticals GAAP EPS of -$2.52
Seeking AlphaMar 28 15:13 ET
Reneo Pharmaceuticals: Q4 Earnings Insights
Reneo Pharmaceuticals (NASDAQ:RPHM) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:35 AM.Here's what investors need to know about the announcement.EarningsReneo Pharmaceuticals mis
BenzingaMar 28 08:00 ET
Express News | Reneo Pharmaceuticals Q4 GAAP EPS $(0.70) Misses $(0.62) Estimate; Cash, Cash Equivalents, And Short-term Investments Of $103M
Moomoo 24/7Mar 28 07:37 ET
Press Release: Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a
Dow JonesMar 28 07:35 ET
Reneo Pharmaceuticals 4Q Loss/Shr 70c >RPHM
Reneo Pharmaceuticals 4Q Loss/Shr 70c >RPHM
Dow JonesMar 28 07:35 ET
No Data
No Data